检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Treatment-Emergent Adverse Events of Interest for Janus Kinase Inhibitors: Pooled Analysis of the 52-Week TRuE-V Phase 3 Studies of Ruxolitinib Cream Treatment for Vitiligo

Amit G. Pandya,Khaled Ezzedine,David Rosmarin,Thierry Passeron,Seemal R. Desai,Mark Lebwohl,Deanna Kornacki,Kang Sun,Kathleen Butler,Albert Wolkerstorfer

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY（2023）

引用 0|浏览1
暂无评分
关键词
janus kinase inhibitors,ruxolitinib cream treatment-emergent,vitiligo
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要